Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Anal human papillomavirus DNA in women at a colposcopy clinic.

D'Hauwers KW, Cornelissen T, Depuydt CE, Bogers J, Donders AR, Leuridan E, Van Damme P, Tjalma WA.

Eur J Obstet Gynecol Reprod Biol. 2012 Sep;164(1):69-73. doi: 10.1016/j.ejogrb.2012.05.014. Epub 2012 Jun 5.

PMID:
22677508
2.

Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study).

Kojic EM, Cu-Uvin S, Conley L, Bush T, Onyekwuluje J, Swan DC, Unger ER, Henry K, Hammer JH, Overton ET, Darragh TM, Palefsky JM, Vellozzi C, Patel P, Brooks JT.

Sex Transm Dis. 2011 Apr;38(4):253-9. doi: 10.1097/OLQ.0b013e3181f70253.

PMID:
20966828
3.

Human papillomavirus DNA and mRNA positivity of the anal canal in women with lower genital tract HPV lesions: predictors and clinical implications.

Valari O, Koliopoulos G, Karakitsos P, Valasoulis G, Founta C, Godevenos D, Dova L, Paschopoulos M, Loufopoulos A, Paraskevaidis E.

Gynecol Oncol. 2011 Sep;122(3):505-8. doi: 10.1016/j.ygyno.2011.05.033. Epub 2011 Jun 12.

PMID:
21665253
4.

Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.

Monsonego J, Zerat L, Syrjänen K, Zerat JC, Smith JS, Halfon P.

Vaccine. 2012 Jul 27;30(35):5215-21. doi: 10.1016/j.vaccine.2012.06.013. Epub 2012 Jun 17.

PMID:
22713720
5.

Evaluation of high-risk human papillomavirus types PCR detection in paired urine and cervical samples of women with abnormal cytology.

Daponte A, Pournaras S, Mademtzis I, Hadjichristodoulou C, Kostopoulou E, Maniatis AN, Messinis IE.

J Clin Virol. 2006 Jul;36(3):189-93. Epub 2006 May 11.

PMID:
16690350
6.

High detection rate of human papillomavirus in anal brushings from women attending a proctology clinic.

Pierangeli A, Scagnolari C, Selvaggi C, Cannella F, Riva E, Impagnatiello A, Bernardi G, Ciardi A, Moschella CM, Antonelli G, Indinnimeo M.

J Infect. 2012 Sep;65(3):255-61. doi: 10.1016/j.jinf.2012.05.004. Epub 2012 May 15.

PMID:
22609230
7.

[Human papillomavirus typing in routine cervical smears. Results from a series of 3778 patients].

Levert M, Clavel C, Graesslin O, Masure M, Birembaut P, Quereux C, Gabriel R.

Gynecol Obstet Fertil. 2000 Oct;28(10):722-8. French.

PMID:
11244634
8.

Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic.

Perrons C, Kleter B, Jelley R, Jalal H, Quint W, Tedder R.

J Med Virol. 2002 Jun;67(2):246-52.

PMID:
11992586
9.

Prevalence and risk factors for human papillomavirus DNA in cervical cytology.

Kasap B, Yetimalar H, Keklik A, Yildiz A, Cukurova K, Soylu F.

Eur J Obstet Gynecol Reprod Biol. 2011 Nov;159(1):168-71. doi: 10.1016/j.ejogrb.2011.06.021. Epub 2011 Jul 18.

PMID:
21764503
10.

Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.

Palefsky JM, Holly EA, Ralston ML, Da Costa M, Greenblatt RM.

J Infect Dis. 2001 Feb 1;183(3):383-91. Epub 2000 Dec 29.

PMID:
11133369
11.

Epidemiological data of different human papillomavirus genotypes in cervical specimens of HIV-1-infected women without history of cervical pathology.

Videla S, Darwich L, Cañadas MP, Paredes R, Tarrats A, Castella E, Llatjos M, Bofill M, Clotet B, Sirera G; HIV-HPV Study Group.

J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):168-75. doi: 10.1097/QAI.0b013e3181938e63.

PMID:
19131892
13.

Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.

Ciotti M, Sesti F, Paba P, Benedetto A, Patrizi L, Criscuolo A, Piccione E, Branca M, Syrjänen K, Favalli C.

Eur J Gynaecol Oncol. 2004;25(5):577-84.

PMID:
15493169
14.

HPV testing in primary screening of older women.

Cuzick J, Beverley E, Ho L, Terry G, Sapper H, Mielzynska I, Lorincz A, Chan WK, Krausz T, Soutter P.

Br J Cancer. 1999 Oct;81(3):554-8.

15.
16.

High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.

Denise Zielinski G, Snijders PJ, Rozendaal L, Voorhorst FJ, Runsink AP, de Schipper FA, Meijer CJ.

J Pathol. 2001 Oct;195(3):300-6.

PMID:
11673826
17.

High levels of HPV-16 DNA are associated with high-grade cervical lesions in women at risk or infected with HIV.

Fontaine J, Hankins C, Mayrand MH, Lefevre J, Money D, Gagnon S, Rachlis A, Pourreaux K, Ferenczy A, Coutlée F; Canadian Women's HIV Study Group.

AIDS. 2005 May 20;19(8):785-94.

PMID:
15867492
18.

Detection of human papillomavirus infection in women attending a colposcopy clinic.

Selva L, Gonzalez-Bosquet E, Rodriguez-Plata MT, Esteva C, Suñol M, Muñoz-Almagro C.

Diagn Microbiol Infect Dis. 2009 Aug;64(4):416-21. doi: 10.1016/j.diagmicrobio.2009.03.005. Epub 2009 Apr 18.

PMID:
19376675
19.

Detection of human papillomavirus DNA in self-administered vaginal swabs as compared to cervical swabs.

Palmisano ME, Gaffga AM, Daigle J, Brinkman J, Mire K, Lenczyk K, Martin DH, Hagensee ME.

Int J STD AIDS. 2003 Aug;14(8):560-7.

PMID:
12935387
20.

Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.

Flores Y, Shah K, Lazcano E, Hernández M, Bishai D, Ferris DG, Lörincz A, Hernández P, Salmerón J; Morelos HPV Study Collaborators.

Salud Publica Mex. 2002 Jul-Aug;44(4):335-44.

PMID:
12216521

Supplemental Content

Support Center